Preclinical CRO Market – Global Industrial Analysis and Forecast (2022-2029)

Global Preclinical CRO Market is expected to grow at a CAGR of 8.06% during the forecast period. Global Preclinical CRO Market is expected to reach US$ 10.59 Bn. by 2029.

Global Preclinical CRO Market Introduction

A preclinical CRO is a support center that provides the research and development skills needed to guide a drug candidate through animal testing and into the clinical stage. Increased early research efforts in the drug development process, as well as increased outsourcing for preclinical CRO services, are driving the market growth. Preclinical CRO services are critical components of successful drug development that is expected to help meet market demand. Global Preclinical CRO Market To know about the Research Methodology :- Request Free Sample Report

Global Preclinical CRO Market Dynamics

The need for preclinical contract research organization (CRO) services has grown in recent years as the R&D budget for drug development has expanded, supporting market growth over the forecast period. Preclinical research initiatives have been hampered by the ongoing Covid-19 epidemic, particularly in the first quarter of 2021. Nonetheless, life-saving medicines must be discovered and commercialized quickly. For many biopharmaceutical companies, preclinical CROs play a critical role in moving the concept to the commercialization stage. In the case of the COVID vaccine, preclinical investigations have been completed at an exponential rate, demonstrating CROs' dominant importance. Increasing expenditure on CRO services is projected to considerably enhance market growth during the forecast period. According to a survey conducted by Servier Research Institute in 2021, toxicological testing is responsible for about 50% of preclinical failure, which is expected to drive demand for preclinical CRO services in the future years. Aside from that, recent legislative changes in Europe pertaining to preclinical CRO services are expected to boost demand for toxicity testing, boosting the regional market growth. The procedure of medicine approved by the Food and Drug Administration has changed dramatically throughout the years (FDA). The United States recently enacted the 21st Century Cures Act, which streamlines the clearance process for breakthrough medicines and medical devices. Changes in approval processes are likely to spur innovation and raise demand for preclinical services, boosting the market growth. In addition, major drivers expected to fuel the growth of the worldwide preclinical CRO market include increased government attention on the development of life-saving medications, as well as growing demand for services such as bioanalysis and DMPK investigations, toxicity testing, and others. Since 2000, PhRMA member businesses have invested almost $1 trillion in R&D, making the biopharmaceutical industry the most R&D-intensive industry in the United States. Also, the growth of the preclinical CRO market is likely to be influenced by the increasing collaborative work approach among the public and government for the creation of innovative goods.

Global Preclinical CRO Market Segment Analysis

Due to an increase in the outsourcing of noncore preclinical CRO studies and strong uptake in toxicology tests, toxicology testing held the biggest revenue share of 61.1 % in 2021. The market for preclinical CRO is divided into three categories based on service: bioanalysis and DMPK research, toxicity testing, and others. Over the forecast period, the bioanalysis and DMPK studies segment is expected to grow at the fastest rate of xx%. A surge in demand for pharmacokinetic services to assist toxicological testing for IND-enabling studies is credited for this profitable growth. For thorough evaluation and analysis of effectiveness and safety data for new drug development, bioanalysis and DMPK investigations are also required. Furthermore, the results of non-clinical toxicological and pharmacological investigations must be compared to those of non-clinical and clinical pharmacokinetic research. In 2021, the biopharmaceutical firms segment had the highest market share of 81.1 %. The rising trend of outsourcing end-to-end services among biopharmaceutical firms, particularly small and mid-size businesses that lack significant competence in the preclinical phase of drug development, is projected to increase demand for preclinical CRO services in the future. Over the forecast period, government and academic institutes are expected to increase the most. The market is divided into biopharmaceutical firms, government and academic institutes, and medical device businesses based on end-use.

Global Preclinical CRO Market Regional Insights

With a market share of 47.7% in 2021, North America led the industry. Due to increased R&D spending and increased adoption of new technologies, the area is anticipated to continue its dominance during the forecast period. Increased availability of trained human resources and decreased gadget costs are also expected to propel the market forward throughout the forecast period. According to a study published by ClinicalTrail.gov, the number of registered preclinical trials has grown dramatically in recent years. According to the study, there were 45,445 preclinical research registered in the United States alone in 2021. Furthermore, the regional industry demand is expected to be fueled by pharmaceutical firms' increased focus on innovative medication development for the treatment of numerous chronic diseases. The rising prevalence of chronic illnesses is boosting demand for preclinical CRO services, which is driving the regional market growth. Due to the cost-effectiveness of preclinical CROs in countries like India and China, Asia Pacific is expected to grow at the fastest rate throughout the forecast period.

Global Preclinical CRO Market Report Scope: Inquire before buying

Global Preclinical CRO Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US $ 5.70 Bn.
Forecast Period 2022 to 2029 CAGR: 8.06% Market Size in 2029: US $ 10.59 Bn.
Segments Covered: by Service • Bioanalysis and DMPK Studies • Toxicology Testing • Others
by End Use • Biopharmaceutical Companies • Government and Academic Institutes • Medical Device Companies

Global Preclinical CRO Market, by Region

• North America • Europe • South America • MEA • Asia Pacific

Global Preclinical CRO Market Key Players

• Envigo Corporation • MPI research • Eurofins Scientific • PRA Health Sciences, Inc. • Wuxi AppTec • Medpace, Inc. • Pharmaceutical Product Development (PPD), LLC • PARAXEL International Corporation • ICON Plc • Laboratory Corporation of America, Inc • Covance Inc. (LabCorp) • MD Biosciences, Inc • Jubilant Biosys • Admescope • Metasafe Frequently Asked Questions: 1. Which region has the largest share in Global Preclinical CRO Market? Ans: North America region held the highest share in 2021. 2. What is the growth rate of Global Preclinical CRO Market? Ans: The Global Preclinical CRO Market is growing at a CAGR of 8.06% during forecasting period 2022-2029. 3. What is scope of the Global Preclinical CRO market report? Ans: Global Preclinical CRO Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Preclinical CRO market? Ans: The important key players in the Global Preclinical CRO Market are – NeuroSky, EMOTIV, Advanced Brain Monitoring Inc., Koninklijke Philips N.V., Medtronic, Muse, Natus Medical Incorporated, Cadwell Industries Inc., NeuroWave Systems Inc., BrainScope., Hangzhou Zhongheng Electric, Deayea, NeuroTherapeutics, and Melon. 5. What is the study period of this market? Ans: The Global Preclinical CRO Market is studied from 2021 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Preclinical CRO Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2021 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Preclinical CRO Market 3.4. Geographical Snapshot of the Preclinical CRO Market, By Manufacturer share 4. Global Preclinical CRO Market Overview, 2021-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Preclinical CRO Market 5. Supply Side and Demand Side Indicators 6. Global Preclinical CRO Market Analysis and Forecast, 2021-2029 6.1. Global Preclinical CRO Market Size & Y-o-Y Growth Analysis. 7. Global Preclinical CRO Market Analysis and Forecasts, 2021-2029 7.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 7.1.1. Bioanalysis and DMPK Studies 7.1.2. Toxicology Testing 7.1.3. Others 7.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 7.2.1. Biopharmaceutical Companies 7.2.2. Government and Academic Institutes 7.2.3. Medical Device Companies 8. Global Preclinical CRO Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2021-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Preclinical CRO Market Analysis and Forecasts, 2021-2029 9.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 9.1.1. Bioanalysis and DMPK Studies 9.1.2. Toxicology Testing 9.1.3. Others 9.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 9.2.1. Biopharmaceutical Companies 9.2.2. Government and Academic Institutes 9.2.3. Medical Device Companies 10. North America Preclinical CRO Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Preclinical CRO Market Analysis and Forecasts, 2021-2029 11.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 11.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 12. Canada Preclinical CRO Market Analysis and Forecasts, 2021-2029 12.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 12.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 13. Mexico Preclinical CRO Market Analysis and Forecasts, 2021-2029 13.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 13.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 14. Europe Preclinical CRO Market Analysis and Forecasts, 2021-2029 14.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 14.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 15. Europe Preclinical CRO Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Preclinical CRO Market Analysis and Forecasts, 2021-2029 16.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 16.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 17. France Preclinical CRO Market Analysis and Forecasts, 2021-2029 17.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 17.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 18. Germany Preclinical CRO Market Analysis and Forecasts, 2021-2029 18.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 18.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 19. Italy Preclinical CRO Market Analysis and Forecasts, 2021-2029 19.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 19.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 20. Spain Preclinical CRO Market Analysis and Forecasts, 2021-2029 20.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 20.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 21. Sweden Preclinical CRO Market Analysis and Forecasts, 2021-2029 21.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 21.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 22. CIS Countries Preclinical CRO Market Analysis and Forecasts, 2021-2029 22.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 22.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 23. Rest of Europe Preclinical CRO Market Analysis and Forecasts, 2021-2029 23.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 23.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 24. Asia Pacific Preclinical CRO Market Analysis and Forecasts, 2021-2029 24.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 24.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 25. Asia Pacific Preclinical CRO Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Preclinical CRO Market Analysis and Forecasts, 2021-2029 26.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 26.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 27. India Preclinical CRO Market Analysis and Forecasts, 2021-2029 27.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 27.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 28. Japan Preclinical CRO Market Analysis and Forecasts, 2021-2029 28.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 28.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 29. South Korea Preclinical CRO Market Analysis and Forecasts, 2021-2029 29.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 29.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 30. Australia Preclinical CRO Market Analysis and Forecasts, 2021-2029 30.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 30.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 31. ASEAN Preclinical CRO Market Analysis and Forecasts, 2021-2029 31.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 31.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 32. Rest of Asia Pacific Preclinical CRO Market Analysis and Forecasts, 2021-2029 32.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 32.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 33. Middle East Africa Preclinical CRO Market Analysis and Forecasts, 2021-2029 33.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 33.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 34. Middle East Africa Preclinical CRO Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Preclinical CRO Market Analysis and Forecasts, 2021-2029 35.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 35.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 36. GCC Countries Preclinical CRO Market Analysis and Forecasts, 2021-2029 36.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 36.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 37. Egypt Preclinical CRO Market Analysis and Forecasts, 2021-2029 37.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 37.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 38. Nigeria Preclinical CRO Market Analysis and Forecasts, 2021-2029 38.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 38.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 39. Rest of ME&A Preclinical CRO Market Analysis and Forecasts, 2021-2029 39.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 39.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 40. South America Preclinical CRO Market Analysis and Forecasts, 2021-2029 40.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 40.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 41. South America Preclinical CRO Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Preclinical CRO Market Analysis and Forecasts, 2021-2029 42.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 42.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 43. Argentina Preclinical CRO Market Analysis and Forecasts, 2021-2029 43.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 43.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 44. Rest of South America Preclinical CRO Market Analysis and Forecasts, 2021-2029 44.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029 44.2. Market Size (Value) Estimates & Forecast By End Use, 2021-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Preclinical CRO Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. Envigo Corporation 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. MPI research 45.3.3. Eurofins Scientific 45.3.4. PRA Health Sciences, Inc. 45.3.5. Wuxi AppTec 45.3.6. Medpace, Inc. 45.3.7. Pharmaceutical Product Development (PPD), LLC 45.3.8. PARAXEL International Corporation 45.3.9. ICON Plc 45.3.10. Laboratory Corporation of America, Inc 45.3.11. Covance Inc. (LabCorp) 45.3.12. MD Biosciences, Inc 45.3.13. Jubilant Biosys 45.3.14. Admescope 45.3.15. Metasafe 45.3.16. Other Key Players
  • INQUIRE BEFORE BUYING